Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study

Data from cohort study nested in Medicaid Analytic eXtract for 2004-13 (n=1.3-4.1 million, depending on outcome) suggests duloxetine is unlikely to be major teratogen but may be linked to increased risk of postpartum haemorrhage and small increased risk of cardiac malformations


British Medical Journal